Geno Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
as on 21-06-2024
- Paid Up Capital ₹ 3.00 Cr
as on 21-06-2024
- Company Age 49 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.25 Cr
as on 21-06-2024
- Satisfied Charges ₹ 91.96 Cr
as on 21-06-2024
- Revenue 17.50%
(FY 2022)
- Profit -35.47%
(FY 2022)
- Ebitda -32.97%
(FY 2022)
- Net Worth 9.36%
(FY 2022)
- Total Assets 13.45%
(FY 2022)
About Geno Pharmaceuticals
The Corporate was formerly known as Geno Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹27.25 Cr. The company has closed loans amounting to ₹91.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Geno Pharmaceuticals Private Limited India is Teja Gadekar as COMPANY SECRETARY. Dilip Ramacrisna, Pramod Salgaocar, Sagar Salgaocar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24239GA1975PTC000250
- Company No.
000250
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 1975
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- LocationGoa, Goa
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Geno Pharmaceuticals Private Limited offer?
Geno Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Stomach Care, Fever, Skin Care, Sunscreen Products, Facewash.
Who are the key members and board of directors at Geno Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Salgaocar  | Managing Director | 30-Sep-2005 | Current |
| Teja Gadekar | Company Secretary | 15-Sep-2014 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilip Ramacrisna | Director | 01-Jan-1980 | Current |
| Pramod Salgaocar | Whole-Time Director | 30-Sep-2006 | Current |
| Pallavi Salgaocar | Whole-Time Director | 30-Sep-2004 | Current |
| Suriakiran Sinaikunde | Director | 25-Oct-2014 | Current |
| Shivam Salgaocar | Additional Director | 23-Oct-2023 | Current |
Financial Performance and Corporate Structure Insights of Geno Pharmaceuticals.
Geno Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.5% increase. The company also saw a substantial fall in profitability, with a 35.47% decrease in profit. The company's net worth moved up by a moderate rise of 9.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Geno Pharmaceuticals?
In 2022, Geno Pharmaceuticals had a promoter holding of 88.43% and a public holding of 11.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Estilo Property Management Private LimitedActive 4 years 9 monthsSagar Salgaocar and Pallavi Salgaocar are mutual person
Estilo Moderno Ventures Private LimitedActive 4 years 7 monthsSagar Salgaocar and Pallavi Salgaocar are mutual person
Estilo Moderno Realty Private LimitedActive 12 years 2 monthsSagar Salgaocar and Pallavi Salgaocar are mutual person
- Dainty Delights Private LimitedActive 12 years 2 months
Sagar Salgaocar and Pallavi Salgaocar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Mar 2022 | ₹4.23 Cr | Open |
Others Creation Date: 09 Mar 2022 | ₹5.00 Cr | Open |
Canara Bank Creation Date: 26 Dec 2013 | ₹18.00 Cr | Open |
How Many Employees Work at Geno Pharmaceuticals?
Geno Pharmaceuticals has a workforce of 1181 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geno Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geno Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
